Emerging concepts of how β-amyloid proteins and pro-inflammatory cytokines might collaborate to produce an ‘Alzheimer brain’ (Review)

  • Authors:
    • Ilaria Dal Pra
    • Anna Chiarini
    • Raffaella Pacchiana
    • Balu Chakravarthy
    • James F. Whitfield
    • Ubaldo Armato
  • View Affiliations

  • Published online on: March 1, 2008     https://doi.org/10.3892/mmr.1.2.173
  • Pages: 173-178
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Three steps lead to the development of full-blown sporadic or late-onset Alzheimer's disease or dementia (AD). In the young brain, amyloid β-(1-42) (Aβ 42) is a normal aggregation-prone protein product of neuronal activity that is kept at a safe low level by proteolysis in neurons and glial cells, and by expulsion across the blood-brain barrier. But clearance declines with advancing age. Step 1: Because of the normal decline with age of the Aβ 42-clearing mechanisms, toxic amyloid-derived diffusible ligands (ADDLs) made of dodecamers of the aggregation-prone Aβ 42 start accumulating. These Aβ 42 dodecamers selectively target the initially huge numbers of excitatory synapses of neurons and cause them to start slowly dropping, which increasingly impairs plasticity and sooner or later starts noticeably affecting memory formation. At a certain point, this increasing loss of synapses induces the neurons to redirect their still-expressed cell cycle proteins from post-mitotic jobs, such as maintaining synapses, to starting a cell cycle and partially or completely replicating DNA without entering mitosis. The resulting aneuploid or tetraploid neurons survive for as long as 6-12 months as quasi-functional ‘undead zombies’, with developing tangles of hyperphosphorylated τ protein disrupting the vital anterograde axonal transport of mitochondria and other synapse-vital components. Step 2: The hallmark AD plaques appear as Aβ 42 clearance continues to decline and the formation of Aβ 42 non-diffusible fibrils begins in the aging brain. Step 3: A terminal cytokine-driven maëlstrom begins in the aging brain when microglia, the brain's professional macrophages, are activated in and around the plaques. They produce pro-inflammatory cytokines, such as IFN-γ, IL-1β and TNF-α. One of these, IFN-γ, causes the astrocytes enwrapping the neuronal synapses to express their β-secretase (BACE1) genes and produce and release Aβ 42, which can kill the closely apposed neurons by binding to their p75NTR receptors, which generate apoptogenic signals. Astrocytes are also stimulated by the same cytokines to turn on their nitric oxide synthase (NOS)-2 genes and start pouring large amounts of nitric oxide (NO) and its cytocidal derivative peroxynitrite (ONOO−) directly out onto the closely apposed neurons.

Related Articles

Journal Cover

March-April 2008
Volume 1 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Dal Pra I, Chiarini A, Pacchiana R, Chakravarthy B, Whitfield JF and Armato U: Emerging concepts of how β-amyloid proteins and pro-inflammatory cytokines might collaborate to produce an ‘Alzheimer brain’ (Review). Mol Med Rep 1: 173-178, 2008.
APA
Dal Pra, I., Chiarini, A., Pacchiana, R., Chakravarthy, B., Whitfield, J.F., & Armato, U. (2008). Emerging concepts of how β-amyloid proteins and pro-inflammatory cytokines might collaborate to produce an ‘Alzheimer brain’ (Review). Molecular Medicine Reports, 1, 173-178. https://doi.org/10.3892/mmr.1.2.173
MLA
Dal Pra, I., Chiarini, A., Pacchiana, R., Chakravarthy, B., Whitfield, J. F., Armato, U."Emerging concepts of how β-amyloid proteins and pro-inflammatory cytokines might collaborate to produce an ‘Alzheimer brain’ (Review)". Molecular Medicine Reports 1.2 (2008): 173-178.
Chicago
Dal Pra, I., Chiarini, A., Pacchiana, R., Chakravarthy, B., Whitfield, J. F., Armato, U."Emerging concepts of how β-amyloid proteins and pro-inflammatory cytokines might collaborate to produce an ‘Alzheimer brain’ (Review)". Molecular Medicine Reports 1, no. 2 (2008): 173-178. https://doi.org/10.3892/mmr.1.2.173